Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter STEPIn study

Abstract Background To date, biological treatments have been assessed in subjects with a long‐term history of psoriasis and previous failures to systemic and topical therapies. In rheumatoid arthritis and other immune‐mediated inflammatory diseases, early intensive systemic treatment prolongs treatm... View More